This paper introduces the reader to the field of liquid biopsies and cell-free nucleic acids,
focusing on circulating tumor DNA (ctDNA) in breast cancer (BC). BC is the most common …

Despite efforts to improve earlier diagnosis of non-small cell lung cancer (NSCLC), most
patients present with advanced stage disease, which is often associated with poor survival …

Circulating tumor cells (CTCs) are a type of cancer cells that circulate in the peripheral blood
after breaking away from solid tumors and are essential for the establishment of distant …

Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …

Liquid biopsy, including both circulating tumor cells and circulating tumor DNA, is becoming
more popular as a diagnostic tool in the clinical management of breast cancer. Elevated …

Shedding of cancer cells from the primary site or undetectable bone marrow region into the
circulatory system, resulting in clinically overt metastasis or dissemination, is the hallmark of …

This work explores the complex field of HER2 testing in the HER2-low breast cancer era,
with a focus on methodological aspects. We aim to propose clear positions to scientific …

The study of molecular drivers of cancer is an area of rapid growth and has led to the
development of targeted treatments, significantly improving patient outcomes in many …

Simple Summary From detection to monitoring therapeutic response, circulating tumor DNA
has emerged at the forefront of numerous clinical applications in oncology. It provides a non …

The chief goal of the Blood Profiling Atlas in Cancer (BloodPAC) consortium is to promote
collaborative efforts that support the development and implementation of liquid biopsy tests …